Indications and uses
on chest and throat, temporarily relieves cough due to common cold on muscles and jonts, temporarily releives minor aches and pains
on chest and throat, temporarily relieves cough due to common cold on muscles and jonts, temporarily releives minor aches and pains
See important warning under "When using this product" adults + children 2 yrs + over: rub a thick layer on chest + throat or rub on sore aching muscles cover with warm, dry cloth if desired keep clothing loose about throat/chest to help vapors reach the nose/mouth repeat up to three times per 24 hours or as directed by doctor children under 2 years of age: ask a doctor
store at room temperature
Failure to follow these warnings could result in serious consequences
Camphor 4.8%
Eucalyptus oil 1.2%
Menthol 2.6%
cough suppressant & topical analgesic
For external use only; avoid contact with eyes
May cause splattering and result in burns
These could be signs of a serious condition
ask a health professional before use.
In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
See important warning under "When using this product"
cedarleaf oil, nutmeg oil, special petrolatum, spirits of turpentine, thymol
This product is not manufactred or distributed by Procter & Gamble, distributor of Vicks VapoRub.
McKESSON Empowering Healthcare
Another Quality Product Distributed By McKesson
One Post Street, San Francisco, CA 94104
Money Back Guarantee
Please visit us at
www.sunmarkbrand.com
sunmark
COMPARE TO VICKS VAPORUB ACTIVE INGREDIENTS*
NDC 49348-398-96
medicated
chestrub
Topical analgesic
COUGH SUPRESSANT
NET WT 3.53 OZ (100g)
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49348-398-96 | GM - Gram | 49348-398 | 4e4337e8-a44b-4e48-8c74-c01f72f3bd6c | 1 | 2014-05-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (NATURAL) | ACTIVE INGREDIENT | N20HL7Q941 | 1 | |
| EUCALYPTUS OIL | ACTIVE INGREDIENT | 2R04ONI662 | 1 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| CAMPHOR (NATURAL) | ACTIVE MOIETY | N20HL7Q941 | 1 | |
| EUCALYPTUS OIL | ACTIVE MOIETY | 2R04ONI662 | 1 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| CEDAR LEAF OIL | INACTIVE INGREDIENT | BJ169U4NLG | 1 | |
| NUTMEG OIL | INACTIVE INGREDIENT | Z1CLM48948 | 1 | |
| PARAFFIN | INACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| THYMOL | INACTIVE INGREDIENT | 3J50XA376E | 1 | |
| TURPENTINE OIL | INACTIVE INGREDIENT | C5H0QJ6V7F | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49348-398 | 49348-398-96 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CEDAR LEAF OIL | BJ169U4NLG | IACT |
| NUTMEG OIL | Z1CLM48948 | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| TURPENTINE OIL | C5H0QJ6V7F | IACT |
| THYMOL | 3J50XA376E | IACT |
| CAMPHOR (NATURAL) | N20HL7Q941 | ACTIB |
| EUCALYPTUS OIL | 2R04ONI662 | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | SOAP / TOPICAL | 0.4 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, DELAYED RELEASE / ORAL | 0.2 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CAPSULE, EXTENDED RELEASE / ORAL | 100 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| NUTMEG OIL | NUTMEG OIL | Z1CLM48948 | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | SUSPENSION / TOPICAL | 11726 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | CREAM / TOPICAL | 300 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, EXTENDED RELEASE / ORAL | 321 mg | ||
| NUTMEG OIL | NUTMEG OIL | Z1CLM48948 | ELIXIR / ORAL | 4.5 mg/5ml | ||
| THYMOL | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | OINTMENT / RECTAL | 38 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | AEROSOL, FOAM / TOPICAL | 14235 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| THYMOL | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET, COATED / ORAL | 0.07 mg | ||
| PARAFFIN | PARAFFIN | I9O0E3H2ZE | TABLET / ORAL | 0.7 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4b0a4c3a-c614-dac0-e063-6294a90a15c8 | f84e60e3-4ed2-4937-89a1-37befcdfc134 | 2026-02-17 | Warnings, Adverse reactions | 4b0a4c3a-c614-dac0-e063-6294a90a15c8 f84e60e3-4ed2-4937-89a1-37befcdfc134 |
Adverse event summaries are temporarily unavailable. Other product information remains available.